News & Updates
Filter by Specialty:
Psychosis: Has perceived public stigma changed in Hong Kong?
Perceived public stigma (PPS) towards psychosis has remained static over 9 years in Hong Kong, with different education groups showing unique patterns of changes in PPS and endorsement of medication treatment across the years, researchers from the University of Hong Kong (HKU) have reported.
Psychosis: Has perceived public stigma changed in Hong Kong?
04 Nov 2022Vebicorvir plus entecavir safe, effective in chronic HBV patients
The addition of vebicorvir to entecavir in treatment-naïve patients with chronic hepatitis B virus (HBV) infection provides further antiviral activity, with a positive safety and tolerability profile, results of a phase II trial have shown.
Vebicorvir plus entecavir safe, effective in chronic HBV patients
03 Nov 2022Serum cholesterol efflux capacity underpins early AMD
Patients with early age-related macular degeneration (eAMD) appear to have increased serum cholesterol efflux capacity, according to a recent Singapore study. The same is true for polypoidal choroidal vasculopathy (PCV), but not for typical neovascular AMD (tAMD).
Serum cholesterol efflux capacity underpins early AMD
03 Nov 2022NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC
Adding nivolumab to paclitaxel-carboplatin chemotherapy in the neoadjuvant setting boosted progression-free survival (PFS) and overall survival (OS) in patients with resectable stage IIIA–B non-small cell lung cancer (NSCLC), according to results of the phase II NADIM II trial from Spain.
NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC
02 Nov 2022Extended-release nifedipine benefits women with severe pre-eclampsia
Treatment with extended-release nifedipine helps reduce intrapartum acute hypertensive therapy among pre-eclampsia patients with severe features, as reported in a study.